Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Aptose Biosciences Inc T.APS

Alternate Symbol(s):  APTOF

Technology Health Information Services
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company’s clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in... see more

Bullboard (TSX:APS)

View:
1 2 Next
User Avatar Image
(15)
•••
  • BLUEBERRY5X
Post by BLUEBERRY5on Dec 04, 2025 4:09pm

APTOSE : TAKEOVER

Sent: Thursday, December 04, 2025 at 3:59 PM To: wrice@aptose.com Cc: spietropaolo@aptose.com, info@hanmi.co.kr Subject: Fw: NOTE c/o Dr. William Rice December 4, 2025  ...more  
22
User Avatar Image
(15)
•••
  • BLUEBERRY5X
Post by BLUEBERRY5on Dec 04, 2025 2:45pm

TAKEOVER (CAD $2.41) CAN MAINLY BE CHALLENGED IN COURT

APS stands at this very moment BID C$2.10 (1200 shares) - ASK C$2.35 (8900 shares). LEVEL II QUOTES below shows minimal shares for SELL up to C$5.00. Level II Quotes  ...more  
20
User Avatar Image

•••
  • Jonathon BrownX
Post by Jonathon Brownon Dec 04, 2025 6:08am

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure. read article.
Post by Alex1726on Nov 25, 2025 9:00pm

Screwed

TO MY POINT OF VIEW IT WAS TOTALLY PLOTTED AND IT BEGAN WITH THE PRESS RELEASE DATED LAST JUNE THE 17TH: APTOSE CEO PROP UP APTOSE'S FINANCE TO PREVENT COMPANY FROM GOING BUST. THE ONLY EFFECT ...more  
30
Comment by Alex1726on Nov 25, 2025 8:51pm

RE:RE:A VERY UNFAIR OFFER

The debt is $18 712 000 , the number of outstanding shares is 2,552,429 x $2,41 = $6 151353 + $18 712 000 =24 863 353,00 $CDN. That is what they pay for a $1B U.S adressable market ...more  
17
Comment by Alex1726on Nov 25, 2025 8:31pm

RE:A VERY UNFAIR OFFER

I totally agree that this offer is unfair. I have made some phone calls here in Montreal to a lawer firm with no success. Ley me know what we can do. Everything has been plotted. Tus will reach market ...more  
13
User Avatar Image
(15)
•••
  • BLUEBERRY5X
Post by BLUEBERRY5on Nov 20, 2025 7:45pm

A VERY UNFAIR OFFER

According to the APTOSE New Release  Opinion and Formal Valuation Locust Walk Securities, LLC (“Locust Walk”) was retained by the Special Committee to provide financial advice and prepare ...more  
34
Post by Alex1726on Nov 19, 2025 9:10am

Unfair offer

If you think tou have been screwed this morning just express yourself we'll see what we can do with lawers.
9
Post by Alex1726on Apr 17, 2025 7:19pm

Very undervalued.

TUS will be a game changer treating AML. It already proven to be safe and efficacy at 40 mg dose , very eager to see the results at 80 mg. 
85
User Avatar Image
(37)
•••
  • Palindrome808X
Post by Palindrome808on Apr 01, 2025 12:10pm

NASDAQ decides to remove shares from listing...

Said this is due to non compliance of equity... ny savvier trader than me can explain? Thanks in advance
69
User Avatar Image
(15)
•••
  • BLUEBERRY5X
Post by BLUEBERRY5on Feb 27, 2025 3:22pm

E-MAIL TO APTOSE BIOSCIENCES - INVESTOR RELATIONS

  Mrs. Pietropaolo,   I have been a shareholder of both IMUTEC PHARMA, which name changed to LORUS THERAPEUTICS, which name changed to APTOSE BIOSCIENCES.   ...more  
126
User Avatar Image
(476)
•••
  • IseneschalX
Comment by Iseneschalon Feb 20, 2025 10:03am

RE:APTO....19 f'king cents now

Sub 19 now ; )
59
User Avatar Image
(476)
•••
  • IseneschalX
Post by Iseneschalon Feb 20, 2025 10:01am

APTO....19 f'king cents now

No likes  for me ?????
98
User Avatar Image
(476)
•••
  • IseneschalX
Post by Iseneschalon Feb 20, 2025 9:51am

APTO....not to bags !

It got to 25 cents....LoL Lots of new Bagholders....RS coming 
76
1 2 Next
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >